ClinicalTrials.Veeva

Menu

Developmental Endothelial Locus-1, Platelet Count, and Soluble P-selectin in Overweight and Obese Subjects

A

Aswan University Hospital

Status

Completed

Conditions

Overweight and Obesity

Treatments

Diagnostic Test: Developmental endothelial locus-1 (DEL-1)
Diagnostic Test: Platelet count
Diagnostic Test: soluble P-selectin (sP-sel)

Study type

Observational

Funder types

Other

Identifiers

NCT05864079
DEL-1 and sP-sel in obesity

Details and patient eligibility

About

This observational study aims to detect serum levels of Developmental Endothelial Locus-1 (DEL-1), Platelet Count, and Soluble P-selectin (sP-sel) in Overweight and Obese Subjects. The main questions it aims to answer are:

  • Is there a difference in serum DEl-1 levels in overweight and obese subjects compared to normal subjects?
  • Are there any relations between serum DEL-1 levels, sP-sel, and platelet count in overweight and obese subjects ?

Enrollment

66 patients

Sex

Male

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male patients.
  • Age (18-65) years.
  • Healthy overweight and subjects.

Exclusion criteria

  • Patients with cardiovascular diseases.
  • Diabetic patients.
  • Previous history of thrombo-embolic diseases.
  • Patients with hyperthyroidism.
  • Patients with any type of malignancy.
  • Underlying hepatic or renal failure.
  • Major surgery within 60 days.

Trial design

66 participants in 3 patient groups

Control
Description:
22 healthy age-matched normal-weight male subjects (BMI is from 18.5 to \< 25)
Treatment:
Diagnostic Test: soluble P-selectin (sP-sel)
Diagnostic Test: Platelet count
Diagnostic Test: Developmental endothelial locus-1 (DEL-1)
Overweight
Description:
22 healthy overweight male subjects (BMI is from 25 to \< 30). Patients with cardiovascular diseases, any malignancy, hepatic or renal failure, diabetic, hyperthyroid patients, patients with a previous history of thromboembolic diseases, or with a history of major surgery within 60 days will be excluded.
Treatment:
Diagnostic Test: soluble P-selectin (sP-sel)
Diagnostic Test: Platelet count
Diagnostic Test: Developmental endothelial locus-1 (DEL-1)
Obesity
Description:
22 healthy obese male subjects (BMI is ≥ 30). Patients with cardiovascular diseases, any malignancy, hepatic or renal failure, diabetic, hyperthyroid patients, patients with a previous history of thromboembolic diseases, or with a history of major surgery within 60 days will be excluded.
Treatment:
Diagnostic Test: soluble P-selectin (sP-sel)
Diagnostic Test: Platelet count
Diagnostic Test: Developmental endothelial locus-1 (DEL-1)

Trial contacts and locations

1

Loading...

Central trial contact

Asmaa Abdelmageed Muhammed, lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems